secwatch / observer
8-K filed October 29, 2024, 7:59 PM ET ticker OCEA CIK 0001869974
leadership confidence high sentiment neutral materiality 0.65

CEO Elizabeth Ng takes sabbatical; Director M. Michelle Berrey appointed Interim CEO

Ocean Biomedical, Inc.

item 5.02item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Elizabeth Ng

Chief Executive Officer
OCEA · Ocean Biomedical, Inc.
Effective
2024-10-23
Successor
M. Michelle Berrey
Filed
October 29, 2024, 7:59 PM ET
On October 23, 2024, Elizabeth Ng notified the Company’s Board of Directors that she would be taking a sabbatical for personal reasons.
Appointed (interim)

M. Michelle Berrey

Interim Chief Executive Officer
OCEA · Ocean Biomedical, Inc.
Effective
2024-10-23
Filed
October 29, 2024, 7:59 PM ET
Director, M. Michelle Berrey was appointed to act as Interim Chief Executive Officer, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Elizabeth Ng departed as Chief Executive Officer at Ocean Biomedical, Inc..

Action
took a sabbatical
Role
Chief Executive Officer
Exact text from the filing
On October 23, 2024, Elizabeth Ng notified the Company’s Board of Directors that she would be taking a sabbatical for personal reasons.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

M. Michelle Berrey was appointed as Interim Chief Executive Officer at Ocean Biomedical, Inc..

Action
appointed
Role
Interim Chief Executive Officer
Exact text from the filing
Director, M. Michelle Berrey was appointed to act as Interim Chief Executive Officer, effective immediately.
View on SEC.gov

Ocean Biomedical, Inc. filing history →

Source: SEC EDGAR
accession 0001493152-24-042911
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.